Mechanical Thrombectomy Access Score: A Systematic Review and Modified Delphi of Global Barriers to Endovascular Therapy
- PMID: 39450508
- DOI: 10.1161/STROKEAHA.124.047805
Mechanical Thrombectomy Access Score: A Systematic Review and Modified Delphi of Global Barriers to Endovascular Therapy
Abstract
Background: The availability of mechanical thrombectomy (MT) for acute ischemic stroke is limited, and vast disparities exist between countries. We aim to create a MT access score to measure the drivers of access to help quantify and accelerate treatment worldwide.
Methods: We used a systematic review complemented by a modified Delphi method. In the first of 3 rounds, 4 independent investigators performed a systematic literature review using key search terms that drive MT access, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. In the second round, a panel of 6 anonymous international experts selected key attributes needed for scoring. In the final round, a total of 12 attributes were selected on consensus, each given a score on a 0 to 3 scale. An ultimate MT access score (range, 0-36) was proposed as a new tool to use in identifying barriers to MT access and assist in providing an initial framework for public health interventions.
Results: Of 2864 abstracts screened, 121 studies were included in the final systematic review. A total of 34 attributes that potentially drive MT access were initially identified. In the final round, 12 attributes were selected by the expert panel: public awareness, emergency medical services transportation, prehospital large vessel occlusion screening, interhospital transfer policy, emergency department protocols, stroke imaging protocols, emergency department stroke expertise or telestroke availability, interventionalists, MT-capable centers, device availability, and insurance coverage. These attributes were weighted as part of the final score of 0 to 36.
Conclusions: The MT access score represents the first tool to quantify barriers to global MT access. Its implementation stands not just as an academic achievement but as a beacon of hope for improving stroke care and outcomes worldwide, bringing us a step closer to bridging the gap in stroke treatment disparities.
Keywords: Delphi technique; emergency medical services; ischemic stroke; stroke; thrombectomy.
Conflict of interest statement
Dr Ganesh reports grants from MicroVention Inc; compensation from Biogen and Alexion Pharmaceuticals for other services; stock options in SnapDx Inc; and stock holdings in Collavidence Inc. Dr Saver reports compensation from Stream Medical, Boehringer Ingelheim (prevention only), CSL Behring, Johnson & Johnson Health Care Systems Inc, Bayer, BrainQ, Biogen, Roche, BrainsGate, Medtronic USA Inc, Aeromics, and Abbott Laboratories for consultant services; compensation from Occlutech and MIVI Neuroscience for data and safety monitoring services; and stock options in MindRhythm, Rapid Medical, and Neuronics Medical. Dr Kamel reports an ownership stake in TET Medical; compensation from American Medical Association and Javelin Medical for consultant services; compensation from Boehringer Ingelheim, Novo Nordisk, and AstraZeneca for end point review committee services; and compensation from Medtronic and Janssen Biotech for other services. Dr Jauch reports compensation from RapidAI for consultant services. Dr Toth reports compensation from Kaneka Pharma America LLC, Penumbra Inc, and EBSCO for consultant services; and compensation from Medtronic USA Inc for other services. Dr Venkatasubba Rao reports stock holdings in Migegesys; compensation from DECISIO for other services; and compensation from Medical Expert Consulting for expert witness services. Dr Amuluru reports compensation from Medtronic for consultant services. Dr Szeder reports compensation from Medtronic for consultant services. Dr Urrutia reports grants from Genentech. Dr Yavagal reports compensation from Stryker Corporation, Gravity Medical Technology, Vascular Dynamics, Athersys, Johnson & Johnson Health Care Systems Inc, Poseydon, and Medtronic USA Inc for consultant services; and stock options in Rapid Medical, Poseydon, and Athersys. Dr Ortega-Gutierrez reports grants from National Institutes of Health, Methinks, National Institutes of Health, Siemens, MicroVention Inc, and Stryker; compensation from MicroVention Inc, Stryker, and Medtronic for consultant services; and employment by Carver College of Medicine, University of Iowa. The other authors report no conflicts.
Comment in
-
Mechanical Thrombectomy Access Score: A Pragmatic Tool to Quantify Barriers to Global Mechanical Thrombectomy Access.Stroke. 2025 Jan;56(1):168-169. doi: 10.1161/STROKEAHA.124.049403. Epub 2024 Dec 20. Stroke. 2025. PMID: 39705396 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
